Algorithm using Neuron-Specific Enolase and Pro-Gastrin-Releasing Peptide to Increase the Diagnostic Accuracy for Small Cell Lung Cancer

참고문헌 (10)

1. Gazdar AF, "Small-cell lung cancer: what we know, what we need to know and the path forward", Nat Rev Cancer, 17, pp.725~737 (2017)
2. Yang S, "Emerging therapies for small cell lung cancer", J Hematol Oncol, 12, pp.47~ (2019)
3. Shen H, "Low-dose CT for lung cancer screening: opportunities and challenges", Front Med, 12, pp.116~121 (2018)
4. Isgrò MA, "Neuron-specific enolase as a biomarker: biochemical and clinical aspects", Adv Exp Med Biol, 867, pp.125~143 (2015)
5. Nisman B, "The diagnostic and prognostic value of ProGRP in lung cancer", Anticancer Res, 29, pp.4827~4832 (2009)
6. 김혜란, "Plasma proGRP Concentration is Sensitive and Specific for Discriminating Small Cell Lung Cancer from Nonmalignant Conditions or Non-small Cell Lung Cancer", Journal of Korean Medical Science, 26(5), pp.625~630 (2011), 대한의학회
7. Korse CM, "Multicenter evaluation of a new progastrin-releasing peptide (ProGRP) immunoassay across Europe and China", Clin Chim Acta, 438, pp.388~395 (2015)
8. Liu L, "The combination of the tumor markers suggests the histological diagnosis of lung cancer", Biomed Res Int, 2017, pp.2013989~ (2017)
9. Oya Y, "Serum Pro GRP and NSE levels predicting small cell lung cancer transformation in a patient with ALK rearrangement-positive non-small cell lung cancer:A case report", Oncol Lett, 16, pp.4219~4222 (2018)
10. Yang DW, "Role of a serum-based biomarker panel in the early diagnosis of lung cancer for a cohort of high-risk patients", Cancer, 121(S17), pp.3113~3121 (2015)

관련 논문AI추천